Imiquimod
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5773 publications
Majoon Ushba alleviated IL-17A sensitized keratinocyte ferroptosis via JAK-2-STAT-3 signaling axis and reversed imiquimod induced psoriasiform inflammation.
Journal: Pharmaceutical biology
Published: April 13, 2026
Reciprocal regulation of TNF receptor 1-mediated signaling and inflammatory damages by MARCH2 and USP22.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 10, 2026
Disease context dictates the cellular targets of IL-17 in inflammatory skin disease.
Journal: bioRxiv : the preprint server for biology
Published: April 03, 2026
Topical imiquimod in the management of botulinum toxin-induced upper eyelid ptosis: A case series.
Journal: JAAD case reports
Published: March 20, 2026
Two primary melanoma in situ lesions of the vulva: Treatment with imiquimod.
Journal: JAAD case reports
Published: March 19, 2026
A Case of Porokeratosis Ptychotropica Treated with Cryotherapy.
Journal: Acta dermatovenerologica Croatica : ADC
Published: March 10, 2026
Carbon dioxide laser ablation as an alternative or adjunct treatment of Bowenoid in situ carcinoma in five cats.
Journal: Journal of feline medicine and surgery
Published: February 17, 2026
Topical Astaxanthin Attenuates Imiquimod-Induced Psoriasiform Dermatitis by Downregulating Psoriasis-Associated Keratin Gene Expression (Krt16, Krt17, Krt6a) and Inhibiting the JAK-STAT Signaling Pathway.
Journal: Molecules (Basel, Switzerland)
Published: February 16, 2026
Heat Shock Protein 70 Deficient Mice Exhibit Reduced Psoriasis-like Skin Inflammation.
Journal: Biomedicines
Published: February 13, 2026
Clinical and Virologic Outcomes of Topical Imiquimod in Vaginal Intraepithelial Neoplasia: A Retrospective Cohort Study.
Journal: Journal of clinical medicine
Published: February 09, 2026
Last Updated: 04/28/2026